Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516 · see citing works

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151 · see citing works

T cell exhaustion

Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · see citing works

Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775 · see citing works

Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397 · see citing works

Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

Heagerty, P. J., Lumley, T., & PEPE, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,870 · see citing works

The polycomb group protein EZH2 is involved in progression of prostate cancer

Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717 · see citing works

The Polycomb group protein EZH2 directly controls DNA methylation

Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204 · see citing works

Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis

Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204 · see citing works

Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer

Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · see citing works

A human memory T cell subset with stem cell–like properties

Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974 · see citing works

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

McCabe, M. T., Ott, H. M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G. S., Liu, Y., Graves, A. P., III, A. D. P., Diaz, E., et al. (2012) · Nature · doi:10.1038/nature11606 · Cited by 1,786 · see citing works

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Rosenberg, S. A., Restifo, N. P., Yang, J. C.-H., Morgan, R. A., & Dudley, M. E. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2355 · Cited by 1,654 · see citing works

Checking the Cox model with cumulative sums of martingale-based residuals

LIN, D. Y., WEI, L. J., & YING, Z. (1993) · Biometrika · doi:10.1093/biomet/80.3.557 · Cited by 1,432 · see citing works

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314 · see citing works

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

Varambally, S., Cao, Q., Mani, R. S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K., et al. (2008) · Science · doi:10.1126/science.1165395 · Cited by 1,048 · see citing works

Instruction of Distinct CD4 T Helper Cell Fates by Different Notch Ligands on Antigen-Presenting Cells

Amsen, D., Blander, J. M., Lee, G. R., Tanigaki, K., Honjo, T., & Flavell, R. A. (2004) · Cell · doi:10.1016/s0092-8674(04)00451-9 · Cited by 902 · see citing works

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895 · see citing works

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

Kryczek, I., Banerjee, M., Cheng, P. J., Vatan, L., Szeliga, W., Wei, S., Huang, E. H., Finlayson, E. V. A., Simeone, D. M., Welling, T. H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208249 · Cited by 814 · see citing works

T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment

Crespo, J., Sun, H., Welling, T. H., Tian, Z., & Zou, W. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.003 · Cited by 752 · see citing works

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050930 · Cited by 748 · see citing works

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

Almeida, J. R., Price, D. A., Papagno, L., Arkoub, Z. A., Sauce, D., Bornstein, E. R., Asher, T. E., Samri, A., Schnuriger, A., Theodorou, I. D., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070784 · Cited by 708 · see citing works

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

Zou, W., Machelon, V., L’Herminé, A. C., Borvak, J., Mercier‐Nomé, F., Isaeva, T., Wei, S., Krzysiek, R., Durand–Gasselin, I., Gordon, A. N., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1339 · Cited by 653 · see citing works

Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells

Scholler, J., Brady, T., Binder-Scholl, G. K., Hwang, W., Plesa, G., Hege, K. M., Vogel, A. N., Kalos, M. D., Riley, J. L., Deeks, S. G., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003761 · Cited by 651 · see citing works

TH17 cells in tumour immunity and immunotherapy

Zou, W., & Restifo, N. P. (2010) · Nature reviews. Immunology · doi:10.1038/nri2742 · Cited by 626 · see citing works

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

Gaucher, D., Therrien, R., Kettaf, N., Angermann, B., Boucher, G., Filali-Mouhim, A., Moser, J. M., Mehta, R. S., Drake, D. R., Castro, E., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20082292 · Cited by 589 · see citing works

DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation

Miranda, T. B., Cortez, C. C., Yoo, C. B., Liang, G., Abe, M., Kelly, T. K., Márquez, V. E., & Jones, P. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0013 · Cited by 588 · see citing works

Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch

Gubser, P. M., Bantug, G. R., Razik, L., Fischer, M., Dimeloe, S., Höenger, G., Müller-Durovic, B., Jauch, A., & Hess, C. (2013) · Nature Immunology · doi:10.1038/ni.2687 · Cited by 487 · see citing works

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses

Precopio, M., Betts, M. R., Parrino, J., Price, D. A., Emma Gostick, D., Ambrozak, D. R., Asher, T. E., Douek, D. C., Harari, A., Pantaleo, G., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062363 · Cited by 484 · see citing works

Notch promotes survival of pre–T cells at the β-selection checkpoint by regulating cellular metabolism

Ciofani, M., & Zúñiga‐Pflücker, J. C. (2005) · Nature Immunology · doi:10.1038/ni1234 · Cited by 466 · see citing works

Th17 cells are long lived and retain a stem cell-like molecular signature

Muranski, P., Borman, Z. A., Kerkar, S. P., Klebanoff, C. A., Ji, Y., Sanchez-Perez, L., Sukumar, M., Reger, R. N., Yu, Z., Kern, S. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.019 · Cited by 443 · see citing works

Control of T cell viability.

Marrack, P., & Kappler, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104554 · Cited by 439 · see citing works

Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2

Cui, T. X., Kryczek, I., Zhao, L., Zhao, E., Kuick, R. D., Roh, M. H., Vatan, L., Szeliga, W., Mao, Y., Thomas, D. G., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.025 · Cited by 426 · see citing works

The Notch Intracellular Domain Is Ubiquitinated and Negatively Regulated by the Mammalian Sel-10 Homolog

Öberg, C., Li, J., Pauley, A. M., Wolf, E., Gurney, M. E., & Lendahl, U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103992200 · Cited by 412 · see citing works

MYC stimulates EZH2 expression by repression of its negative regulator miR-26a

Sander, S., Bullinger, L., Klapproth, K., Fiedler, K., Kestler, H. A., Barth, T. F. E., Möller, P., Stilgenbauer, S., Pollack, J. R., & Wirth, T. (2008) · Blood · doi:10.1182/blood-2008-03-147645 · Cited by 394 · see citing works

IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L

Kryczek, I., Lin, Y., Nagarsheth, N., Peng, D., Zhao, L., Zhao, E., Vatan, L., Szeliga, W., Dou, Y., Owens, S. R., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.010 · Cited by 389 · see citing works

T Cell Exit from Quiescence and Differentiation into Th2 Cells Depend on Raptor-mTORC1-Mediated Metabolic Reprogramming

Yang, K., Shrestha, S., Zeng, H., Karmaus, P. W. F., Neale, G. A. M., Vogel, P., Guertin, D. A., Lamb, R. F., & Chi, H. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.015 · Cited by 389 · see citing works

Linking Cell Cycle to Asymmetric Division: Aurora-A Phosphorylates the Par Complex to Regulate Numb Localization

Wirtz‐Peitz, F., Nishimura, T., & Knoblich, J. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.049 · Cited by 370 · see citing works

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

Fiskus, W. C., Wang, Y., Sreekumar, A., Buckley, K. M., Shi, H., Jillella, A., Üstün, C., Rao, R., Fernandez, P., Chen, J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-213496 · Cited by 357 · see citing works

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

Harari, A., Bart, P., Stöhr, W., Tapia, G., Garcia, M., Medjitna-Rais, E., Burnet, S., Cellerai, C., Erlwein, O. W., Barber, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071331 · Cited by 299 · see citing works

The Polycomb Protein Ezh2 Regulates Differentiation and Plasticity of CD4+ T Helper Type 1 and Type 2 Cells

Tumes, D. J., Onodera, A., Suzuki, A., Shinoda, K., Endo, Y., Iwamura, C., Hosokawa, H., Koseki, H., Tokoyoda, K., Suzuki, Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.012 · Cited by 291 · see citing works

Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy

Powell, D. J., Dudley, M. E., Robbins, P. F., & Rosenberg, S. A. (2004) · Blood · doi:10.1182/blood-2004-06-2482 · Cited by 291 · see citing works

Human T _H 17 Cells Are Long-Lived Effector Memory Cells

Kryczek, I., Zhao, E., Liu, Y., Wang, Y., Vatan, L., Szeliga, W., Moyer, J., Klimczak, A., Lange, A., & Zou, W. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002949 · Cited by 278 · see citing works

Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells

Kryczek, I., Liu, S., Roh, M. H., Vatan, L., Szeliga, W., Wei, S., Banerjee, M., Mao, Y., Kotarski, J., Wicha, M. S., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25967 · Cited by 267 · see citing works

The precursors of memory: models and controversies

Ahmed, R., Bevan, M. J., Reiner, S. L., & Fearon, D. T. (2009) · Nature reviews. Immunology · doi:10.1038/nri2619 · Cited by 202 · see citing works

Role of Deltex-1 as a Transcriptional Regulator Downstream of the Notch Receptor

Yamamoto, N., Yamamoto, S.-I., Inagaki, F. F., Kawaichi, M., Fukamizu, A., Kishi, N., Matsuno, K., Nakamura, K., Weinmaster, G., Okano, H., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105245200 · Cited by 189 · see citing works

A Molecular Basis for the Control of Preimmune Escape Variants by HIV-Specific CD8+ T Cells

Ladell, K., Hashimoto, M., Iglesias, M. C., Wilmann, P. G., McLaren, J. E., Gras, S., Chikata, T., Kuse, N., Fastenackels, S., Emma Gostick, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.021 · Cited by 149 · see citing works

Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo

Zheng, Y., Zha, Y., Driessens, G., Locke, F. L., & Gajewski, T. F. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120342 · Cited by 106 · see citing works

Ezh2 Regulates Transcriptional and Posttranslational Expression of T-bet and Promotes Th1 Cell Responses Mediating Aplastic Anemia in Mice

Tong, Q., He, S., Xie, F., Mochizuki, K., Liu, Y., Mochizuki, I., Meng, L., Sun, H., Zhang, Y., Guo, Y., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302943 · Cited by 67 · see citing works

Th17 cells have stem cell-like features and promote long-term immunity

Wei, S., Zhao, E., Kryczek, I., & Zou, W. (2012) · OncoImmunology · doi:10.4161/onci.19440 · Cited by 49 · see citing works

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

Zou, W., Wolchok, J. D., & Chen, L. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7118 · Cited by 2,382 · see citing works

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.49 · Cited by 2,217 · see citing works

Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

Pitt, J. M., Marabelle, A., Eggermont, A. M. M., Soria, J., Kroemer, G., & Zitvogel, L. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw168 · Cited by 1,344 · see citing works

Metabolic Instruction of Immunity

Buck, M. D., Sowell, R., Kaech, S. M., & Pearce, E. L. (2017) · Cell · doi:10.1016/j.cell.2017.04.004 · Cited by 1,232 · see citing works

Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion

Leone, R. D., Zhao, L., Englert, J. M., Sun, I.-M., Oh, M.-H., Sun, I.-H., Arwood, M. L., Bettencourt, I. A., Patel, C. H., Wen, J., et al. (2019) · Science · doi:10.1126/science.aav2588 · Cited by 1,169 · see citing works

EZH2: a novel target for cancer treatment

Duan, R., Du, W., & Guo, W. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00937-8 · Cited by 946 · see citing works

Metabolism of immune cells in cancer

Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877 · see citing works

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

Scharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R. E., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.009 · Cited by 848 · see citing works

Unraveling the Complex Interplay Between T Cell Metabolism and Function

Geltink, R. I. K., Kyle, R. L., & Pearce, E. L. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053019 · Cited by 821 · see citing works

Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor

Maj, T., Wang, W., Crespo, J., Zhang, H., Wang, W., Wei, S., Zhao, L., Vatan, L., Shao, I., Szeliga, W., et al. (2017) · Nature Immunology · doi:10.1038/ni.3868 · Cited by 733 · see citing works

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

Scharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.009 · Cited by 705 · see citing works

Cancer SLC43A2 alters T cell methionine metabolism and histone methylation

Bian, Y., Li, W., Kremer, D. M., Sajjakulnukit, P., Li, S., Crespo, J., Nwosu, Z. C., Zhang, L., Czerwonka, A., Pawłowska, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2682-1 · Cited by 654 · see citing works

Targeting the epigenetic regulation of antitumour immunity

Hogg, S. J., Beavis, P. A., Dawson, M. A., & Johnstone, R. W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0077-5 · Cited by 653 · see citing works

The hallmarks of cancer immune evasion

Galassi, C., Chan, T. A.-T., Vitale, I., & Galluzzi, L. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.09.010 · Cited by 595 · see citing works

Regulatory circuits of T cell function in cancer

Speiser, D. E., Ho, P., & Verdeil, G. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.80 · Cited by 559 · see citing works

FBXW7: a critical tumor suppressor of human cancers

Yeh, C., Bellon, M., & Nicot, C. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0857-2 · Cited by 513 · see citing works

Epigenetic control of CD8+ T cell differentiation

Henning, A. N., Roychoudhuri, R., & Restifo, N. P. (2018) · Nature reviews. Immunology · doi:10.1038/nri.2017.146 · Cited by 501 · see citing works

Reversing T-cell Dysfunction and Exhaustion in Cancer

Zarour, H. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1849 · Cited by 462 · see citing works

Resistance Mechanisms to Anti-PD Cancer Immunotherapy

Vesely, M. D., Zhang, T., & Chen, L. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-070621-030155 · Cited by 468 · see citing works

Fates of CD8+ T cells in Tumor Microenvironment

Maimela, N. R., Liu, S., & Zhang, Y. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.11.004 · Cited by 459 · see citing works

Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer

Li, W., Tanikawa, T., Kryczek, I., Xia, H., Li, G., Wu, K., Wei, S., Zhao, L., Vatan, L., Wen, B., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.022 · Cited by 448 · see citing works

Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential

Gan, L., Yang, Y., Li, Q., Feng, Y., Liu, T., & Guo, W.-J. (2018) · Biomarker Research · doi:10.1186/s40364-018-0122-2 · Cited by 428 · see citing works

Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer

Wang, W., Kryczek, I., Dostál, L., Lin, H., Tan, L., Zhao, L., Lu, F., Wei, S., Maj, T., Peng, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.009 · Cited by 423 · see citing works

The spectrum of T cell metabolism in health and disease

Bantug, G. R., Galluzzi, L., Kroemer, G., & Hess, C. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.99 · Cited by 421 · see citing works

Notch signaling pathway in cancer: from mechanistic insights to targeted therapies

Shi, Q., Xue, C., Zeng, Y., Yuan, X., Chu, Q., Jiang, S., Wang, J., Zhang, Y., Zhu, D., & Li, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01828-x · Cited by 428 · see citing works

Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets

Yang, J., Xu, J., Wang, W. T., Zhang, B., Yu, X., & Shi, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01480-x · Cited by 404 · see citing works

Signal pathways of melanoma and targeted therapy

Guo, W., Wang, H., & Li, C. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00827-6 · Cited by 403 · see citing works

Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma

Siska, P. J., Beckermann, K. E., Mason, F. M., Andrejeva, G., Greenplate, A. R., Sendor, A. B., Chiang, Y.-C. J., Corona, A. L., Gemta, L. F., Vincent, B. G., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93411 · Cited by 389 · see citing works

T Cell Dysfunction and Exhaustion in Cancer

Zhang, Z., Liu, S., Zhang, B., Qiao, L., Zhang, Y., & Zhang, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00017 · Cited by 385 · see citing works

Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment

Zhao, Y., Shao, Q., & Peng, G. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0344-8 · Cited by 382 · see citing works

Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression

Cong, J., Wang, X., Zheng, X., Wang, D., Fu, B., Sun, R., Tian, Z., & Wei, H. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.021 · Cited by 376 · see citing works

Mechanisms regulating T-cell infiltration and activity in solid tumors

Lanitis, E., Dangaj, D., Irving, M., & Coukos, G. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx238 · Cited by 369 · see citing works

T Cell Dysfunction in Cancer Immunity and Immunotherapy

Xia, A., Zhang, Y., Jiang, X., Yin, T., & Lu, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01719 · Cited by 338 · see citing works

The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy

Lim, A. R., Rathmell, W. K., & Rathmell, J. C. (2020) · eLife · doi:10.7554/elife.55185 · Cited by 330 · see citing works

The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy

Zingg, D., Arenas-Ramirez, N., Şahin, D., Rosalia, R. A., Antunes, A. T., Häusel, J., Sommer, L., & Boyman, O. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.007 · Cited by 329 · see citing works

Immunometabolism of regulatory T cells

Newton, R. H., Priyadharshini, B., & Turka, L. A. (2016) · Nature Immunology · doi:10.1038/ni.3466 · Cited by 328 · see citing works

Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer

Granier, C., Guillebon, É. D., Blanc, C., Roussel, H., Badoual, C., Colin, E., Saldmann, A., Gey, A., Oudard, S. M., & Tartour, É. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000213 · Cited by 323 · see citing works

Programmed Cell Death Tunes Tumor Immunity

Liu, J., Hong, M., Li, Y., Chen, D., Wu, Y., & Hu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847345 · Cited by 319 · see citing works

Metabolic interventions in the immune response to cancer

O’Sullivan, D., Sanin, D. E., Pearce, E. J., & Pearce, E. L. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0140-9 · Cited by 314 · see citing works

Metabolic adaptation of lymphocytes in immunity and disease

Chapman, N. M., & Chi, H.-B. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.012 · Cited by 263 · see citing works

Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy

Liu, X., Hartman, C. L., Li, L., Albert, C. J., Si, F., Gao, A., Huang, L. J., Zhao, Y., Lin, W., Hsueh, E. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz6314 · Cited by 278 · see citing works

The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8+ T Cell Fitness and Functionality

Li, C., Zhu, B., Son, Y. M., Wang, Z., Jiang, L., Xiang, M., Ye, Z., Beckermann, K. E., Wu, Y., Jenkins, J. W., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.013 · Cited by 244 · see citing works

EZH2-Targeted Therapies in Cancer: Hype or a Reality

Eich, M., Athar, M., Ferguson, J. E., & Varambally, S. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2147 · Cited by 246 · see citing works

Early transcriptional and epigenetic regulation of CD8+ T cell differentiation revealed by single-cell RNA sequencing

Kakaradov, B., Arsenio, J., Widjaja, C. E., He, Z., Aigner, S., Metz, P. J., Yu, B., Wehrens, E. J., Lopez, J. M., Kim, S. H., et al. (2017) · Nature Immunology · doi:10.1038/ni.3688 · Cited by 231 · see citing works

The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy

Cai, J., Wang, D., Zhang, G., & Guo, X. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s221340 · Cited by 240 · see citing works

Wnt signaling pathway in cancer immunotherapy

Zhou, Y., Jiang, X., Luo, H., Meng, X., Chen, M., & Zhu, D. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.034 · Cited by 238 · see citing works

Metabolic Control of CD8+ T Cell Fate Decisions and Antitumor Immunity

Zhang, L., & Romero, P. J. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.11.005 · Cited by 233 · see citing works

Tissue-resident memory T cells in tumor immunity and immunotherapy

Okła, K., Färber, D. L., & Zou, W. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201605 · Cited by 230 · see citing works

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis

Huang, Y., Cai, K., Xu, P., Wang, L., Huang, C., Fang, Y., Cheng, S., Sun, X., Liu, F., Huang, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00437-8 · Cited by 228 · see citing works

Immunometabolism in systemic lupus erythematosus

Morel, L. M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.43 · Cited by 216 · see citing works

Immunomodulation by targeted anticancer agents

Petroni, G., Buqué, A., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.11.009 · Cited by 212 · see citing works

T‐cell metabolism governing activation, proliferation and differentiation; a modular view

Dimeloe, S., Burgener-Gasser, A.-V., Grählert, J., & Hess, C. (2016) · Immunology · doi:10.1111/imm.12655 · Cited by 200 · see citing works

Metabolism in tumor microenvironment: Implications for cancer immunotherapy

Shi, R., Tang, Y., & Miao, H. (2020) · MedComm · doi:10.1002/mco2.6 · Cited by 198 · see citing works

Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy

Kouidhi, S., Ayed, F. B., & Elgaaïed, A. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00353 · Cited by 193 · see citing works

EZH2 inhibitor GSK126 suppresses antitumor immunity by driving production of myeloid-derived suppressor cells

Huang, S., Wang, Z., Zhou, J., Huang, J., Zhou, L., Luo, J., Wan, Y. Y., Long, H., & Zhu, B. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2395 · Cited by 185 · see citing works

Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment

Nachef, M., Ali, A. K., Almutairi, S. M., & Lee, S.-H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624324 · Cited by 176 · see citing works

Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors

Middelburg, J., Kemper, K., Engelberts, P. J., Labrijn, A. F., Schuurman, J., & van Hall, T. (2021) · Cancers · doi:10.3390/cancers13020287 · Cited by 174 · see citing works

Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression

Guo, L., Zhang, P., Chen, Z., Xia, H., Li, S., Zhang, Y., Kobberup, S., Zou, W., & Lin, J. D. (2017) · Journal of Clinical Investigation · doi:10.1172/jci96324 · Cited by 169 · see citing works

The Notch signaling pathway: a potential target for cancer immunotherapy

Li, X., Yan, X., Wang, Y., Kaur, B., Han, H., & Yu, J. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01439-z · Cited by 174 · see citing works

FBXW7 in Cancer: What Has Been Unraveled Thus Far?

Sailo, B. L., Banik, K., Girisa, S., Bordoloi, D., Fan, L., Halim, C. E., Wang, H., Kumar, A. P., Zheng, D., Mao, X., et al. (2019) · Cancers · doi:10.3390/cancers11020246 · Cited by 167 · see citing works

TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy

Huang, L., Xu, H., & Peng, G. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2018.4 · Cited by 165 · see citing works

Metabolism drives macrophage heterogeneity in the tumor microenvironment

Li, S., Yu, J., Huber, A. K., Kryczek, I., Wang, Z., Jiang, L., Li, X., Du, W., Li, G., Wei, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110609 · Cited by 166 · see citing works

Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective

Liu, J., Bai, Y., Li, Y., Li, X., & Luo, K. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105301 · Cited by 165 · see citing works

SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells

Stephen, T. L., Payne, K. K., Chaurio, R. A., Allegrezza, M. J., Zhu, H., Pérez‐Sanz, J., Perales‐Puchalt, A., Nguyen, J. M., Vara-Ailor, A., Eruslanov, E. B., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.015 · Cited by 160 · see citing works

Microenvironmental Metabolism Regulates Antitumor Immunity

Ngwa, V. M., Edwards, D. N., Philip, M., & Chen, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0617 · Cited by 154 · see citing works

Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine

Kumagai, S., Itahashi, K., & Nishikawa, H. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00870-6 · Cited by 163 · see citing works

Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target

Garnier, D., Renoult, O., Alves‐Guerra, M., Paris, F., & Pecqueur, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00118 · Cited by 152 · see citing works

Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells

Hamaidi, I., Zhang, L., Kim, N., Wang, M.-H., Iclozan, C., Fang, B., Liu, M., Koomen, J. M., Berglund, A., Yoder, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.008 · Cited by 148 · see citing works

Suppression of FIP200 and autophagy by tumor-derived lactate promotes naïve T cell apoptosis and affects tumor immunity

Xia, H., Wang, W., Crespo, J., Kryczek, I., Li, W., Wei, S., Bian, Z., Maj, T., He, M., Liu, J. R., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan4631 · Cited by 155 · see citing works

Immune checkpoint inhibitors in cancer therapy

Eika, S., Peng, L., Baleeiro, R. B., Nicholas, R., Ming, Y., & Yaohe, W. (2017) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160168 · Cited by 150 · see citing works

Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function

Xu, H., Du, X., Xu, J., Zhang, Y., Tian, Y., Liu, G., Wang, X., Ma, M., Du, W., Liu, Y., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000603 · Cited by 147 · see citing works

Fbxw7 increases CCL2/7 in CX3CR1hi macrophages to promote intestinal inflammation

He, J., Song, Y., Li, G., Xiao, P., Liu, Y., Xue, Y., Cao, Q., Tu, X., Pan, T. S., Jiang, Z., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123374 · Cited by 145 · see citing works

Epigenetic mechanisms regulating T-cell responses

Schmidl, C., Delacher, M., Huehn, J., & Feuerer, M. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.07.014 · Cited by 144 · see citing works

Supercharging adoptive T cell therapy to overcome solid tumor–induced immunosuppression

Mardiana, S., Solomon, B., Darcy, P. K., & Beavis, P. A. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw2293 · Cited by 136 · see citing works

Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease

Majumder, S., Thieme, K., Batchu, S. N., Alghamdi, T. A., Bowskill, B. B., Kabir, M. G., Liu, Y., Advani, S. L., White, K., Geldenhuys, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95946 · Cited by 127 · see citing works

Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance

Wei, F., Wang, D., Wei, J., Tang, N., Tang, L. M., Xiong, F., Guo, C. J., Zhou, M., Li, X., Li, G., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03581-0 · Cited by 128 · see citing works

Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis

Xia, H., Li, S., Li, X., Wang, W., Bian, Y., Wei, S., Grove, S., Wang, W., Vatan, L., Liu, J. R., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.141115 · Cited by 125 · see citing works

Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity

Scharping, N. E., & Delgoffe, G. M. (2016) · Vaccines · doi:10.3390/vaccines4040046 · Cited by 119 · see citing works

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma

Sun, H.-W., Yu, X.-J., Wu, W., Chen, J., Shi, M., Zheng, L., & Xu, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168907 · Cited by 120 · see citing works

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck

Zandberg, D. P., Menk, A. V., Velez, M., Normolle, D., DePeaux, K., Liu, A., Ferris, R. L., & Delgoffe, G. M. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002088 · Cited by 119 · see citing works

CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma

Gu, Y., Li, X., Bi, Y., Zheng, Y., Wang, J., Li, X., Huang, Z., Chen, L., Huang, Y., & Huang, Y. (2020) · Aging · doi:10.18632/aging.102656 · Cited by 119 · see citing works

Epigenetic Reprogramming in Naive CD4+ T Cells Favoring T Cell Activation and Non‐Th1 Effector T Cell Immune Response as an Early Event in Lupus Flares

Coit, P., Dozmorov, M. G., Merrill, J. T., McCune, W. J., Maksimowicz‐McKinnon, K., Wren, J. D., & Sawalha, A. H. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39720 · Cited by 118 · see citing works

Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy

Lian, X., Yang, K., Li, R., Li, M., Zuo, J., Zheng, B., Wang, W., Wang, P., & Zhou, S. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01486-5 · Cited by 120 · see citing works

Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer

Jones, B. A., Varambally, S., & Arend, R. C. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0437 · Cited by 115 · see citing works

Beggars banquet: Metabolism in the tumor immune microenvironment and cancer therapy

Zou, W., & Green, D. R. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.003 · Cited by 115 · see citing works

Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling

Tsukumo, S., & Yasutomo, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00101 · Cited by 112 · see citing works

Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions

Pansy, K., Uhl, B., Krstić, J., Szmyra, M., Fechter, K., Santiso, A., Thüminger, L., Greinix, H., Kargl, J., Prochazka, K. T., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413311 · Cited by 110 · see citing works

Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma

Tsou, P., Campbell, P. L., Amin, M. A., Coit, P., Miller, S. D., Fox, D. A., Khanna, D., & Sawalha, A. H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1813006116 · Cited by 109 · see citing works

The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia

Qorraj, M., Bruns, H., Böttcher, M., Weigand, L., Saul, D., Mackensen, A., Jitschin, R., & Mougiakakos, D. (2016) · Leukemia · doi:10.1038/leu.2016.214 · Cited by 104 · see citing works

Anti-VEGF Treatment Enhances CD8+ T-cell Antitumor Activity by Amplifying Hypoxia

de Almeida, P. E., Mak, J., Hernandez, G., Jesudason, R., Hérault, A., Javinal, V., Borneo, J., Kim, J. M., & Walsh, K. B. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0360 · Cited by 103 · see citing works

LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade

Liu, Y., Debo, B. M., Li, M., Shi, Z., Sheng, W., & Shi, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-27179-7 · Cited by 103 · see citing works

RNA m 1 A methylation regulates glycolysis of cancer cells through modulating ATP5D

Wu, Y., Chen, Z., Xie, G., Zhang, H., Wang, Z., Zhou, J., Chen, F., Li, J., Chen, L., Niu, H., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119038119 · Cited by 102 · see citing works

Metabolic reprograming of anti-tumor immunity

Sukumar, M., Kishton, R. J., & Restifo, N. P. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.03.011 · Cited by 100 · see citing works

miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA

Hua, S., Liu, C., Liu, L., & Wu, D. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.112 · Cited by 99 · see citing works

Metabolic regulation of immune responses: therapeutic opportunities

Aßmann, N., & Finlay, D. K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83005 · Cited by 96 · see citing works

Epigenetic Control of the Tumor Microenvironment

Marks, D. L., Olson, R. L., & Fernández-Zapico, M. E. (2016) · Epigenomics · doi:10.2217/epi-2016-0110 · Cited by 91 · see citing works

Extracellular vesicles as antigen carriers for novel vaccination avenues

Mehanny, M., Lehr, C., & Fuhrmann, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.016 · Cited by 88 · see citing works

Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition

Kim, H. J., Cantor, H., & Cosmopoulos, K. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.08.010 · Cited by 87 · see citing works

Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway

Zhang, T., Xia, W., Song, X., Mao, Q., Huang, X., Chen, B., Liang, Y., Wang, H., Chen, Y., Yu, X., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01331-2 · Cited by 85 · see citing works

miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate

Ji, Y., Fioravanti, J., Zhu, W., Wang, H., Wu, T., Hu, J., Lacey, N. E., Gautam, S., Gall, J. B. L., Yang, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09882-8 · Cited by 87 · see citing works

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction (TUM9P.1007)

Zhao, E., Maj, T., Kryczek, I., Wei, S., Crespo, J., Wan, S., Vatan, L., Szeliga, W., Chinnaiyan, A. M., Welling, T. H., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.194.supp.210.9 · Cited by 1 · see citing works

Glycolysis and EZH2 boost T cell weaponry against tumors

Bantug, G. R., & Hess, C. (2015) · Nature Immunology · doi:10.1038/ni.3346 · Cited by 4 · see citing works

Abstract 1029: Epigenetic control of tumor-infiltrating lymphocyte metabolic-exhaustion

Koss, B. S., Shields, B. D., Taylor, E. M., Storey, A. J., Byrum, S. D., Gies, A. J., Washam, C. L., Choudhury, S. R., Ahn, J. H., Uryu, H., et al. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-1029

Tumor-mediated suppression of T cells is EZ(H2)

Foley, J. F. (2016) · Science Signaling · doi:10.1126/scisignal.aaf2209

Abstract SY17-01: Metabolic impact on immune cell subsets in the tumor microenvironment and its therapeutic relevance

Zou, W. (2018) · Cancer Research · doi:10.1158/1538-7445.am2018-sy17-01 · Cited by 1 · see citing works